Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Cg Oncology Inc (CGON)

234 + Investors. Track Smart Money conviction in CGON. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +41
Streak
9Q ▲
Buyers last Q
63%

Smart Money Signals — CGON

Based on 235 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 9 quarters in a row

last 6Q
For 9 consecutive quarters, more hedge funds added CGON than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
235 hedge funds hold CGON right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +68% more funds vs a year ago

fund count last 6Q
+95 new funds entered over the past year (+68% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 63% buying

149 buying88 selling
Last quarter: 149 funds were net buyers (64 opened a brand new position + 85 added to an existing one). Only 88 were sellers (65 trimmed + 23 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+21 vs last Q)

new funds entering per quarter
Funds opening a new CGON position: 41 → 33 → 43 → 64. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔄

Mostly new holders — 43% entered in last year

■ 23% conviction (2yr+) ■ 35% medium ■ 43% new
Only 53 funds (23%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Value +61% but shares only +9% — price-driven

Value
+61%
Shares
+8%
Last quarter: the total dollar value of institutional holdings rose +61%, but actual share count only changed +9%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📈

Growing discovery — still being found

27 → 41 → 33 → 43 → 64 new funds/Q
New funds entering each quarter: 41 → 33 → 43 → 64. A growing number of institutions are discovering CGON each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
📊

Mixed cohorts — 3% veterans, 52% new entrants

■ 3% veterans ■ 45% 1-2yr ■ 52% new
Of 245 current holders: 8 (3%) held 2+ years, 110 held 1–2 years, 127 (52%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
✅

Strong quality — 36% AUM from major funds

36% from top-100 AUM funds
53 of 231 holders rank in the top 100 by AUM, accounting for 36% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.8
out of 10
Moderate Exit Risk
Exit risk score 4.8/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CGON

In 2026 Q1, 149 hedge funds were net buyers of CGON (64 opened a new position, 85 added to an existing one), while 88 reduced or exited (65 trimmed, 23 sold completely) — a 63% buyer ratio, indicating clear institutional accumulation. This marks 9 consecutive quarters of net institutional buying — a persistent conviction signal. 36% of total institutional value in CGON is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +41 funds (more new holders than closures). Total institutional holders: 235.

Hedge Fund Ownership: CGON

How many hedge funds hold CGON — quarterly history vs. share price
Quarterly hedge fund ownership of CGON vs. share price

Market Analysis: CGON

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CGON

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Cg Oncology Inc (CGON) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much CGON has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 80d ago
CGON
nan%
XLV
+2.1%

CGON outperformed XLV by nan% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 35d ago
CGON
nan%
XLV
+3.2%

Since the filing became public, CGON outperformed XLV by nan% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

24 top-rated funds 10 high-conviction
Consensus
6.1
/ 10
breadth
×
Elite
4.0
/ 10
conviction
Hedge Fund Positioning: CGON
234 + Investors

Track Smart Money conviction in CGON. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 234 194 20.62%
13F Shares 92M 85M 8.58%
Total Value $5.44B $3.37B 61.29%
New Positions 63 43 +20
Increased Positions 83 73 +10
Closed Positions 23 24 -1
Reduced Positions 61 50 +11
Total Calls 9 7 28.57%
Total Puts 4 3 33.33%
PUT/CALL Ratio 0.44 0.43 Bullish

Statistics: CGON

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

234 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CGON. Verified SEC 13F-HR filings.

QUARTER:
Top 25 CGON holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Decheng Capital LLC 65.21% 6,371,669 $431.2M
2 Foresite Capital Management VI LLC 32.67% 2,221,474 $150.3M
3 Seven Fleet Capital Management LP 30.92% 1,439,393 $97.4M
4 Foresite Capital Management V, LLC 25.08% 1,004,050 $68.0M
5 Acorn Capital Advisors, LLC 21.77% 1,130,501 $76.6M
6 TCG Crossover Management, LLC 7.11% 3,670,206 $248.4M
7 Elmind Capital, LP 5.61% 291,800 $19.7M
8 Rtw Investments, LP 4.70% 6,984,808 $472.7M
9 Caligan Partners LP 4.05% 900,000 $60.9M
10 EcoR1 Capital, LLC 3.17% 1,102,000 $74.6M
11 Rosalind Advisors, Inc. 2.72% 100,000 $6.8M
12 Stempoint Capital LP 2.70% 205,622 $13.9M
13 DV Trading LLC 2.31% 1,439,393 $97.4M
14 Braidwell LP 2.22% 984,783 $66.7M
15 Logos Global Management LP 1.94% 575,000 $38.9M
16 Seven Fleet Capital Management LP 1.63% 75,758 $5.1M
17 Orbimed Advisors LLC 1.27% 948,267 $64.2M
18 Silverarc Capital Management, LLC 1.15% 166,349 $11.3M
19 PFM Health Sciences, LP 1.02% 165,925 $11.2M
20 Opaleye Management Inc. 0.85% 94,800 $6.4M
21 ADAR1 Capital Management, LLC 0.74% 185,699 $12.6M
22 Driehaus Capital Management LLC 0.50% 999,623 $67.7M
23 Caption Management, LLC 0.48% 1,220,400 $82.6M
24 Caption Management, LLC 0.46% 1,160,000 $78.5M
25 Sicart Associates LLC 0.43% 25,000 $1.7M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Cg Oncology Inc (CGON)

What does the Smart Money Trend signal show for CGON?

Buying streak — 9 quarters in a row: For 9 consecutive quarters, more hedge funds added CGON than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CGON?

More buyers than sellers — 63% buying: Last quarter: 149 funds were net buyers (64 opened a brand new position + 85 added to an existing one). Only 88 were sellers (65 trimmed + 23 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for CGON holders?

Strong quality — 36% AUM from major funds: 53 of 231 holders rank in the top 100 by AUM, accounting for 36% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held CGON?

Mostly new holders — 43% entered in last year: Only 53 funds (23%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Cg Oncology Inc (CGON) following the 2026 Q1 hedge fund 13F filings?

As of today, CGON has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), CGON has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →